FIG 1.
Adverse events by (A) AML type and (B) cohort. AML, acute myeloid leukemia; ND-AML, newly diagnosed acute myeloid leukemia; R/R-AML, relapsed or refractory acute myeloid leukemia; SSTI, skin and soft tissue infection.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.